Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564K Buy
16,316
+18
+0.1% +$636 ﹤0.01% 1771
2026
Q1
$594K Sell
16,298
-4,827
-23% -$182K ﹤0.01% 1603
2025
Q4
$791K Buy
21,125
+3,264
+18% +$116K ﹤0.01% 1352
2025
Q3
$594K Sell
17,861
-70
-0.4% -$2.45K ﹤0.01% 1356
2025
Q2
$653K Buy
17,931
+4,259
+31% +$146K 0.01% 1208
2025
Q1
$449K Buy
13,672
+636
+5% +$20.1K ﹤0.01% 1192
2024
Q4
$371K Sell
13,036
-6,256
-32% -$162K ﹤0.01% 1220
2024
Q3
$483K Buy
19,292
+3,152
+20% +$75.9K 0.01% 890
2024
Q2
$370K Buy
16,140
+241
+2% +$5.84K 0.02% 644
2024
Q1
$390K Buy
+15,899
New +$382K 0.05% 318
2023
Q2
Sell
-6,300
Closed -$219K 198
2023
Q1
$219K Hold
6,300
0.11% 156
2022
Q4
$234K Hold
6,300
0.12% 151
2022
Q3
$204K Hold
6,300
0.12% 164
2022
Q2
$243K Hold
6,300
0.14% 144
2022
Q1
$228K Hold
6,300
0.13% 168
2021
Q4
$289K Hold
6,300
0.17% 134
2021
Q3
$269K Hold
6,300
0.17% 138
2021
Q2
$292K Hold
6,300
0.19% 121
2021
Q1
$258K Hold
6,300
0.19% 122
2020
Q4
$220K Hold
6,300
0.18% 121
2020
Q3
$208K Hold
6,300
0.21% 112
2020
Q2
$200K Buy
+6,300
New +$191K 0.24% 109

Other funds holding UGI

&Partners's UGI Position: Q2 2026 in Review

&Partners increased its UGI (UGI) stake by 0.11% in Q2 2026, buying an estimated $636 and bringing the position to 16,316 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

&Partners first reported a position in UGI in Q2 2020 and has held it in 22 quarters since. The position peaked at $791K in Q4 2025. 623 funds tracked by Wall St. Rank hold UGI as of Q2 2026.

  • &Partners held 16,316 shares of UGI worth $564K as of Q2 2026.
  • &Partners bought 18 UGI shares in Q2 2026, an estimated $636.
  • UGI made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1771 holding.
  • &Partners first reported a position in UGI in Q2 2020 and has held it in 22 quarters since.
  • &Partners's UGI position peaked at $791K in Q4 2025.
  • 623 funds tracked by Wall St. Rank held UGI as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.